Natural history of atypical parkinsonian syndromes: a multi-center observation
Official title: Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
Run by Second Affiliated Hospital of Soochow University · NCT07805967 · Data updated 2026-11-12
This study follows people with APS like MSA, DLB, PSP, and CBD to see how their symptoms and brain images change over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Second Affiliated Hospital of Soochow University Academic / other |
| Locations | 20 sites (Changshu, Jiangsu and 19 other locations) |
| Status | Recruiting |
| Started | November 12, 2025 |
| Main results expected | August 31, 2030 |
| Study ends | August 31, 2030 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07805967 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with probable MSA, probable DLB, probable PSP-Richardson syndrome, or probable CBD diagnosed within the past three years (MSA) or meeting respective diagnostic criteria, able to undergo serial assessments and imaging.
✕Probably not a fit
Patients who already have advanced disease beyond early stages or who are unable to participate in serial follow-up may derive little direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, multi-center study aimed at detailing how motor and non-motor symptoms progress in atypical parkinsonian syndromes. Researchers will document clinical features and imaging patterns to create a comprehensive assessment framework. The project builds clinical and biological databases to identify biomarkers that may predict disease trajectory. No experimental treatments are given; data collection is purely observational. Participants are followed over time to characterize the natural history of these conditions.
Why it matters
Potential benefit: Successful completion could improve understanding of progression and help identify biomarkers for earlier and more accurate prognosis.
How similar studies have gone: Previous observational efforts in APS have yielded valuable natural history data and biomarker insights, though this study adds multi-center data and standardized assessment frameworks.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. MSA : Meets the "probable MSA" criteria in the 2022 Chinese expert consensus on MSA diagnosis (MSA-P or MSA-C subtype); disease duration ≤3 years (from onset of first motor symptoms) . 2. DLB : Meets "probable DLB" criteria per the 2017 McKeith diagnostic criteria; MMSE ≥18 (to exclude severe dementia confounding assessment) . 3. PSP : Meets "probable PSP-Richardson syndrome" criteria per the 2017 PSP diagnostic standards; vertical gaze palsy or postural instability with duration ≤2 years . 4. CBD : Meets "probable CBD" criteria per the 2019 Chinese expert consensus on corticobasal degeneration diagnosis and treatment; asymmetric cortical symptoms (apraxia/dystonia/alien limb). Exclusion Criteria: 1. Parkinson's disease , spinocerebellar ataxia (SCA) and other secondary autonomic failure . 2. Vascular parkinsonism , Parkinsonism caused by stroke , tumor , or immune-mediated encephalitis .
Where it's running
-
Changshu Hospital Affiliated to Nanjing University of Chinese Medicine
Changshu, Jiangsu, China Recruiting -
Jiangsu Province (Suqian) Hospital
Suqian, Jiangsu, China Recruiting -
The Forth Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China Recruiting -
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China Recruiting -
Yancheng Third People's Hospital
Yancheng, Jiangsu, China Recruiting -
The Forth People's Hospital of Zhenjiang
Zhenjiang, Jiangsu, China Recruiting
Show 14 more locations
-
The second People's Hospital of Huai'an
Huai'an, Jiangsu, China Not yet recruiting -
The First People's Hospial of Kunshan
Kunshan, Jiangsu, China Not yet recruiting -
Jiangsu Province Official Hospital
Nanjing, Jiangsu, China Not yet recruiting -
The Second Affiliated Hospital of Nantong University
Nantong, Jiangsu, China Not yet recruiting -
The Second Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China Not yet recruiting -
Affiliated Hospital of Yangzhou University
Yangzhou, Jiangsu, China Not yet recruiting -
Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine/Zhangjiagang Traditional Chinese Medicine Hospital
Zhangjiagang, Jiangsu, China Not yet recruiting -
Yantai Yuhuangding Hospital
Yantai, Shandong, China Not yet recruiting -
Mianyang 404 Hospital
Mianyang, Sichuan, China Not yet recruiting -
Jiaxing Second Hospital
Jiaxing, Zhejiang, China Not yet recruiting -
Deyang People's Hospital
Deyang, China Not yet recruiting -
Changxing people' s hospital
Huzhou, China Not yet recruiting -
Affiliated Hospital of Nantong University
Nantong, China Not yet recruiting -
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, China Not yet recruiting
Study contacts
- Study coordinator: Jinru Zhang, PhD. MD.
- Email: zhangjinruruby@126.com
- Phone: +8615850210657
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genetic program for Progressive Supranuclear Palsy and related conditions
This study is collecting DNA from adults with Progressive Supranuclear Palsy and similar conditions to see how genetics might help improve diagnosis and care for patients.
-
Synaptic Loss in Multiple System Atrophy
This study looks at how losing connections between brain cells affects people with multiple system atrophy.
-
Longitudinal study of frontotemporal lobar degeneration
This study is trying to learn more about frontotemporal lobar degeneration by following both affected individuals and their family members over time to see how the condition develops.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases
This study collects blood and genetic samples from people with neurodegenerative diseases and their families to build a shared resource for studying disease risk and biology.
-
Longitudinal registry of people with multiple system atrophy in China
This study follows Chinese patients with multiple system atrophy over time to describe how the disease starts and progresses and to compare with people with Parkinson's and healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.